Sina M, Pedram M, Ghojazadeh M, Kochaki A, Aghbali A. P53 gene codon 72 polymorphism in patients with oral squamous cell carcinoma in the population of northern Iran. Med Oral Patol Oral Cir Bucal. 2014 Nov 1;19 (6):e550-5.  

 

 

doi:10.4317/medoral.19794

http://dx.doi.org/doi:10.4317/medoral.19794

 

 

1. Shen H, Zheng Y, Sturgis EM, Spitz MR, Wei Q. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett. 2002;183:123-30.
http://dx.doi.org/10.1016/S0304-3835(02)00117-9

 

2. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88:323-31.
http://dx.doi.org/10.1016/S0092-8674(00)81871-1

 

3. Hanel W, Moll UM. Links between mutant p53 and genomic instability. Journal of cellular biochemistry. 2012;113:433-9.
http://dx.doi.org/10.1002/jcb.23400

 

4. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature. 1998;393:229-34.
http://dx.doi.org/10.1038/30400

 

5. Katiyar S, Thelma BK, Murthy NS, Hedau S, Jain N, Gopalkrishna V, et al. Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem. 2003;252:117-24.
http://dx.doi.org/10.1023/A:1025546610920

 

6. Zhu ZZ, Wang AZ, Jia HR, Jin XX, He XL, Hou LF, et al. Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population. Japanese journal of clinical oncology. 2007;37:385-90.
http://dx.doi.org/10.1093/jjco/hym034

 

7. Soulitzis N, Sourvinos G, Dokianakis DN, Spandidos DA. p53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett. 2002;179:175-83.
http://dx.doi.org/10.1016/S0304-3835(01)00867-9

 

8. Wang-Gohrke S, Becher H, Kreienberg R, Runnebaum IB, Chang-Claude J. Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years. Pharmacogenetics. 2002;12:269-72.
http://dx.doi.org/10.1097/00008571-200204000-00012

 

9. Wirtenberger M, Frank B, Hemminki K, Klaes R, Schmutzler RK, Wappenschmidt B, et al. Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer. Carcinogenesis. 2006;27:1655-60.
http://dx.doi.org/10.1093/carcin/bgi374

 

10. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Molecular and cellular biology. 1999;19:1092-100.

 

11. Sargeran K, Murtomaa H, Safavi SM, Vehkalahti M, Teronen O. Malignant oral tumors in iran: ten-year analysis on patient and tumor characteristics of 1042 patients in Tehran. The Journal of craniofacial surgery. 2006;17:1230-3.
http://dx.doi.org/10.1097/01.scs.0000246728.23483.ce

 

12. Andisheh-Tadbir A, Mehrabani D, Heydari ST. Epidemiology of squamous cell carcinoma of the oral cavity in Iran. The Journal of craniofacial surgery. 2008;19:1699-702.
http://dx.doi.org/10.1097/SCS.0b013e31818c04cc

 

13. Falaki F, Dalirsani Z, Pakfetrat A, Falaki A, Saghravanian N, Nosratzehi T, et al. Clinical and histopathological analysis of oral squamous cell carcinoma of young patients in Mashhad, Iran: a retrospective study and review of literature. Medicina oral, patologia oral y cirugia bucal. 2011;16:e473-7.
http://dx.doi.org/10.4317/medoral.16.e473

 

14. Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA, et al. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nature genetics. 2000;25:47-54.
http://dx.doi.org/10.1038/75586

 

15. Gudleviciene Z, Didziapetriene J, Ramael M, Uleckiene S, Valuckas KP. Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients. Gynecologic oncology. 2006;102:530-3.
http://dx.doi.org/10.1016/j.ygyno.2006.01.019

 

16. Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Human mutation. 2007;28:622-9.
http://dx.doi.org/10.1002/humu.20495

 

17. Brant O, Hoffmann M, Kanappilly A, Gorogh T, Gottschlich S. P53 codon 72 polymorphism in squamous cell carcinoma of the head and neck region. Anticancer research. 2007;27:3301-5.

 

18. Liu G, Miller DP, Zhou W, Thurston SW, Fan R, Xu LL, et al. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. Cancer research. 2001;61:8718-22.

 

19. Twu CW, Jiang RS, Shu CH, Lin JC. Association of p53 codon 72 polymorphism with risk of hypopharyngeal squamous cell carcinoma in Taiwan. J Formos Med Assoc. 2006;105:99-104.
http://dx.doi.org/10.1016/S0929-6646(09)60330-2

 

20. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF. A systematic review of genetic polymorphisms and breast cancer risk. Cancer epidemiology, biomarkers & prevention. 1999;8:843-54.

 

21. Humbey O, Cairey-Remonnay S, Guérrini JS, Algros MP, Mougin C, Bittard H, et al. Detection of the human papillomavirus and analysis of the TP53 polymorphism of exon 4 at codon 72 in penile squamous cell carcinomas. Eur J Cancer. 2003;39:684-90.
http://dx.doi.org/10.1016/S0959-8049(02)00835-3

 

22. Suzuki K, Matsui H, Ohtake N, Nakata S, Takei T, Nakazato H, et al. A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese. Journal of biomedical science. 2003;10:430-5.
http://dx.doi.org/10.1007/BF02256434

 

23. Zhang ZW, Newcomb P, Hollowood A, Feakins R, Moorghen M, Storey A, et al. Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma. Clinical cancer research. 2003;9:2151-6.

 

24. Hamel N, Black MJ, Ghadirian P, Foulkes WD. No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck. British journal of cancer. 2000;82:757-9.
http://dx.doi.org/10.1054/bjoc.1999.0993

 

25. Summersgill KF, Smith EM, Kirchner HL, Haugen TH, Turek LP. p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:334-9.
http://dx.doi.org/10.1067/moe.2000.107359

 

26. Bau DT, Tsai MH, Lo YL, Hsu CM, Tsai Y, Lee CC, et al. Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients. Anticancer research. 2007;27:1559-64.

 

27. Sankaranarayanan R. Oral cancer in India: an epidemiologic and clinical review. Oral Surg Oral Med Oral Pathol. 1990;69:325-30.
http://dx.doi.org/10.1016/0030-4220(90)90294-3

 

28. Jovanovic A, Schulten EA, Kostense PJ, Snow GB, van der Waal I. Squamous cell carcinoma of the lip and oral cavity in The Netherlands; an epidemiological study of 740 patients. J Craniomaxillofac Surg. 1993;21:149-52.
http://dx.doi.org/10.1016/S1010-5182(05)80103-9

 

29. Otoh EC, Johnson NW, Olasoji HO, Danfillo IS, Adeleke OA. Intra-oral carcinomas in Maiduguri, north-eastern Nigeria. Oral Dis. 2005;11:379-85.
http://dx.doi.org/10.1111/j.1601-0825.2005.01134.x

 

30. Chidzonga MM. Oral malignant neoplasia: a survey of 428 cases in two Zimbabwean hospitals. Oral oncology. 2006;42:177-83.
http://dx.doi.org/10.1016/j.oraloncology.2005.07.003

 

31. Izarzugaza MI, Esparza H, Aguirre JM. Epidemiological aspects of oral and pharyngeal cancers in the Basque Country. J Oral Pathol Med. 2001;30:521-6.
http://dx.doi.org/10.1034/j.1600-0714.2001.300902.x